Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Teradata Corp
TDC
5
Collegium Pharmaceutical
COLL
(Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 0.60%700.95M | 3.27%2.79B | 1.76%654.65M | 8.66%724.95M | 3.66%710.23M | -0.86%696.74M | -2.40%2.7B | -5.74%643.35M | -4.15%667.15M | -5.32%685.13M |
Operating revenue | 0.60%700.95M | 3.27%2.79B | 1.76%654.65M | 8.66%724.95M | 3.66%710.23M | -0.86%696.74M | -2.40%2.7B | -5.74%643.35M | -4.15%667.15M | -5.32%685.13M |
Cost of revenue | -3.22%464.92M | -1.33%1.9B | -4.13%446.96M | 3.36%481.11M | 0.47%491.77M | -4.83%480.37M | -9.34%1.93B | -7.31%466.22M | -15.02%465.45M | -13.54%489.49M |
Gross profit | 9.09%236.02M | 14.74%886.35M | 17.25%207.69M | 20.89%243.84M | 11.66%218.46M | 9.25%216.37M | 20.61%772.51M | -1.35%177.13M | 36.01%201.71M | 24.23%195.64M |
Operating expense | 0.78%76.15M | 2.36%296.31M | -1.14%74.93M | 7.27%74.32M | 0.15%71.5M | 3.51%75.57M | 1.44%289.47M | 8.24%75.79M | -0.43%69.28M | -3.37%71.4M |
Selling and administrative expenses | -3.13%42.98M | 13.17%171.41M | 14.36%42.08M | 12.67%42.12M | 14.43%42.84M | 11.34%44.37M | 4.39%151.47M | 2.78%36.8M | 6.23%37.39M | -2.73%37.44M |
Research and development costs | 6.33%33.18M | -9.49%124.9M | -15.77%32.84M | 0.94%32.19M | -15.59%28.66M | -5.90%31.2M | -1.61%138M | 13.95%38.99M | -7.25%31.89M | -4.06%33.96M |
Operating profit | 13.54%159.87M | 22.15%590.04M | 31.01%132.76M | 28.01%169.52M | 18.28%146.95M | 12.60%140.8M | 36.02%483.05M | -7.48%101.34M | 68.21%132.43M | 48.63%124.24M |
Net non-operating interest income expense | 31.65%-10.7M | -53.55%-57.37M | -63.78%-11.65M | -53.53%-14.16M | -55.14%-15.91M | -45.31%-15.65M | -6.13%-37.36M | 31.26%-7.11M | -10.18%-9.22M | -44.76%-10.26M |
Non-operating interest expense | -31.65%10.7M | 53.55%57.37M | 63.78%11.65M | 53.53%14.16M | 55.14%15.91M | 45.31%15.65M | 6.13%37.36M | -31.26%7.11M | 10.18%9.22M | 44.76%10.26M |
Other net income (expense) | 19.10%14.94M | 18.86%51.44M | 26.34%13.13M | 22.41%13.81M | 11.46%11.95M | 15.32%12.55M | 55.69%43.28M | 14.21%10.4M | 13.11%11.28M | 17.82%10.72M |
Special income (charges) | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
Other non- operating income (expenses) | 19.10%14.94M | 18.86%51.44M | 26.34%13.13M | 22.41%13.81M | 11.46%11.95M | 15.32%12.55M | 22.45%43.28M | 14.21%10.4M | 13.11%11.28M | 17.82%10.72M |
Income before tax | 19.19%164.11M | 19.46%584.11M | 28.32%134.25M | 25.79%169.17M | 14.66%142.99M | 10.02%137.69M | 40.61%488.96M | -3.39%104.62M | 67.41%134.48M | 45.68%124.71M |
Income tax | 27.38%38.16M | 21.57%121.69M | -2.90%23.51M | 58.59%36.85M | 25.07%31.37M | 8.69%29.96M | 46.78%100.1M | 36.27%24.21M | 35.85%23.24M | 31.09%25.09M |
Net income | 16.91%125.95M | 18.91%462.41M | 37.72%110.74M | 18.94%132.32M | 12.04%111.62M | 10.40%107.73M | 39.11%388.86M | -11.17%80.41M | 75.95%111.25M | 49.87%99.62M |
Net income continuous Operations | 16.91%125.95M | 18.91%462.41M | 37.72%110.74M | 18.94%132.32M | 12.04%111.62M | 10.40%107.73M | 39.11%388.86M | -11.17%80.41M | 75.95%111.25M | 49.87%99.62M |
Minority interest income | ||||||||||
Net income attributable to the parent company | 16.91%125.95M | 18.91%462.41M | 37.72%110.74M | 18.94%132.32M | 12.04%111.62M | 10.40%107.73M | 39.11%388.86M | -11.17%80.41M | 75.95%111.25M | 49.87%99.62M |
Preferred stock dividends | ||||||||||
Other preferred stock dividends | 28.69%480K | 23.38%1.65M | 42.61%405K | 20.61%474K | 12.36%400K | 21.90%373K | 52.85%1.34M | -5.65%284K | 89.86%393K | 84.46%356K |
Net income attributable to common stockholders | 16.87%125.47M | 18.90%460.76M | 37.70%110.33M | 18.94%131.85M | 12.04%111.22M | 10.36%107.36M | 39.07%387.53M | -11.19%80.13M | 75.91%110.85M | 49.77%99.27M |
Basic earnings per share | 18.08%13.26 | 19.24%48.22 | 37.95%11.56 | 18.88%13.79 | 12.26%11.63 | 11.30%11.23 | 45.62%40.44 | -9.50%8.38 | 83.54%11.6 | 58.41%10.36 |
Diluted earnings per share | 18.08%13.26 | 19.24%48.22 | 37.95%11.56 | 18.88%13.79 | 12.26%11.63 | 11.30%11.23 | 45.62%40.44 | -9.50%8.38 | 83.54%11.6 | 58.41%10.36 |
Dividend per share | 10.00%2.75 | 12.99%10 | 11.11%2.5 | 11.11%2.5 | 11.11%2.5 | 19.05%2.5 | 5.36%8.85 | 7.14%2.25 | 7.14%2.25 | 7.14%2.25 |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |